Subclinical lung health impairment in young adulthood may provide evidence of an intermediate phenotype in the pathogenesis of heart failure later in life.
FDA accepts sNDA for Zoryve (roflumilast) cream 0.05% to treat mild to moderate atopic dermatitis in infants aged 3 to 24 months; PDUFA date set for Feb 2027.
Challenging patient interactions adversely influence emergency physicians' emotions, according to results of a recent study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results